A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination.
Jones E. et al, (2021), Microorganisms, 9
Vi-specific serological correlates of protection for typhoid fever.
Jin C. et al, (2021), The Journal of experimental medicine, 218
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
Gibani MM. et al, (2020), PLoS Negl Trop Dis, 14
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model.
Gibani MM. et al, (2019), Nat Med, 25, 1082 - 1088
IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model.
Dahora LC. et al, (2019), Front Immunol, 10
The impact of vaccination and prior exposure on stool shedding of salmonella typhi and salmonella paratyphi a in six controlled human infection studies
GIBANI M. et al, (2018), Clinical Infectious Diseases
Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model
Juel HB. et al, (2018), FRONTIERS IN IMMUNOLOGY, 8
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
Jin C. et al, (2017), Lancet (London, England)
Natural and Vaccine-Mediated Immunity to Salmonella Typhimurium is Impaired by the Helminth Nippostrongylus brasiliensis
Bobat S. et al, (2014), PLoS Neglected Tropical Diseases, 8